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Two isoforms of the macrophage migration inhibitory factor (MIF) have been isolated to homogeneity from bovine brain cytosol. In agreement 
with the cDNA sequence of their human counterpart, they both have an apparent molecular weight of 12 kDa and are characterized by the following 
N-terminal amino acid sequence NH,-PMFVVNTNVPRASVPDGLLSELTQQLAQATGKPPQYIAV-. CD spectra revealed that bovine MIF 
contains 42% (+ 3%) a-helix and 21% (+ 3%) /I-structure. CD-constrained prediction of the secondary structure assigned MIF to the al/?-class of 
proteins. 
Macrophage migration inhibitory factor; Circular dichroism; Secondary structure prediction 
1. INTRODUCTION 
The macrophage migration inhibitory factor (MIF) 
was the first lymphokine to be discovered as a soluble 
component which was capable of inhibiting in vitro 
migration of macrophages [1,2]. The physiological ef- 
fects of MIF were also correlated with delayed hy- 
persensitivity, cellular immunity and the immobiliza- 
tion of macrophages in the sites of chronic inflamma- 
tion [l-l 11. The MIF activity was also detected in vari- 
ous inflammatory processes [3], including allograft re- 
jection [4,5] and rheumatoid polyarthritis [6]. It is be- 
lieved that MIF is generated by stimulated subsets of 
T-cells, and its physiological functions are augmented 
by other early gene products elicited by stimulated T- 
cells, notably y-interferon and interleukin-4 [7,11]. MIF 
in a mixture with mineral oils and an antigen (bovine 
serum albumin or HIV virus 120 kDa glycoprotein) 
appeared to be a potent adjuvant of macrophages and 
T-cells, comparable to that of complete Freund ad- 
juvant [lO,ll]. 
Despite the fact that MIF was the first lymphokine 
to be discovered it has never been isolated to homogene- 
ity from any mammalian tissue. Therefore the cDNA 
sequence of MIF has been elucidated using functional 
expression cloning from a cDNA library of lectin-stim- 
ulated human T-cell hybridoma cell line [S]. Human 
Correspondence address: A. Galat, Departement d’hrgemerie et 
d’Etudes des Prottines (DIEP), Centre d’Etudes de Saclay, Bat. 152. 
F-91 191 Gif-sur-Yvette Cedex, France. Fax: (33) (1) 69 08 91 37. 
The sequence of the N-terminal fragment of bovine MIF has been 
deposited to the Protein Sequence Data Bank (EMBL), accession no. 
P80177. 
MIF is encoded by a 115 amino acid residue long 
polypeptide chain the sequence of which is unrelated to 
any other protein [8]. Although the 12 kDa recombinant 
human MIF possesses in vitro activity in inhibiting the 
migration of human blood monocytes [lo] and acts as 
a potent adjuvant of different lymphoid cells [lO,l 11, no 
direct evidence exists to support its cDNA sequence. 
Here we report on the purification and partial charac- 
terization of a 12 kDa MIF-like protein isolated from 
bovine brain cytosol. 
2. MATERIALS AND METHODS 
2.1. Tissue sources, chemicals, chromatography materials and gel elec- 
trophoresis 
Calf brain was supphed fresh on ice by the Henri Meunier slaughter 
house (Meaux, 77, France). The fresh tissue was shredded and frozen 
in liquid nitrogen. Acrylamide. NJ’-methylenebisacrylamide, ammo- 
nium persulfate, N,N,N,K-tetramethylenediamine were purchased 
from Serva. Pharmalyte 8-10.5 and Ampholite 9-l 1 were from Phar- 
macia/LKB. Molecular weight markers were purchased from Bio-Rad 
and Sigma. PBEl18 and CM-sepharose were from Pharmacia/LKB, 
and DE52 from Whatman. All other chemicals were of analytical 
grade and purchased from either Serva or Sigma. SDS-PAGE gels 
(12%. 20 x 20 cm) were performed according to standard procedures 
and visualized by silver staining [12]. 
2.2. Preparation of tissue samples and primary processrng of soluble 
proteins 
The frozen tissue was dry-homogenized with a Waring blender and 
dispersed in buffer containing 0.250 M NaCl, 10% glycerol, 50 mM 
Tris, pH 7.2 at 4°C. 5 mM B-mercaptoethanol (B-ME), 0.02% NaN, 
and 1 mM PMSF. The mixture was centrifuged for 30 min at 8,000 x g 
and the supernatant was further centrifuged at 37,000 x g for 3 h. The 
resulting supernatant was concentrated from 4 I to about 450 ml m a 
3 kDa dialysis bag (Spectrum) using polyethylene glycol (Sigma, mol. 
wt. approx. 15.000 Da). The final protein solution was dialyzed 
against 50 mM Tris buffer (pH 6.8) containing 10% (v/v) of ethylene 
glycol, 5 mM B-ME and 1 mM PMSF. 
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2.3. Primary sortmg of proteins: anion exchange chromatography 
The concentrated supernatant (usually about 450 ml) was applied 
onto a DE-52 column (5 x 100 cm) equilibrated with 50 mM Tris, pH 
6.85, 10% glycerol, 2 mM B-ME, 1 mM PMSF. The proteins were 
eluted with the equilibration buffer (on average 70 fractions, 12 ml 
each). Fractions were collected at a speed of about 40 ml/h. 
(about 20 ml volume). The column was washed with 5 void ~01s. of 
the equilibrating buffer, and proteins were eluted with the Ampholite 
S-10.5 (1:45 v/v in water, pH 8.0). The fractions (5 ml each) were 
collected at a speed of about 20 ml/h. The pH of each fraction was 
measured with a pH electrode. 
2.4. Fractionation of basic proteins, chromarofocusing on PBEllB 
PBEll8 was loaded onto a 1.6 x 20 cm column and equilibrated 
with 0.025 M triethylamine-HCl (pH 11). The mixture of basic pro- 
teins was concentrated using a PM10 membrane in a stirred cell, 
followed by extensive dialysis against 0.025 M triethylamine-HCl, pH 
11. The equilibrated mixture of proteins was applied onto the column 
2.5. Final purzficatlon of bovme MIF on a weak cation errhanger 
The fractions containing the mixture of proteins with ~1’s from 10.5 
to 9.2 were applied directly onto a CM-Sepharose column equilibrated 
with IO mM phosphate, pH 7.2, 2 mM B-ME and 1 mM PMSF. The 
MIF isoforms were eluted in a gradient of salt from 10 mM to 1 M 
NaCl. 
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Fig. 1. SDS-PAGE analysis of the two last purification steps of MIF from calf brain cytosol. (A) Aliquots from 11 fractions from chromatofocusing 
were fractionated on a 12% SDS-polyacrylamide gel and visualized by silver staining. Lane 1-l 1 show proteins in fractions with the following pHs; 
(1) 8.7, (2) 8.9, (3) 9.1, (4) 9.2, (5) 9.3, (6) 9.5, (7) 9.7, (8) 9.8, (9) 10.0. (11) 10.20; lane 12 shows molecular weight markers (Bio-Rad). (B) Aliquots 
of selected fractions from a CM-Sepharose column were applied on a 12% SDS-polyacrylamide gel and visualized by silver staining. Lane 1, Bio-Rad 
molecular weight markers; lanes 2 and 3, two isoforms of bovine MIF eluted at 0.30 and 0.25 M NaCl; lanes 4-9, other proteins eluted from 
CM-Sepharose. Salt concentration decreases from 2 to 9. 
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2.6 NEPHGE/SDS-PAGE (2D gels) 
About 5 pg of proteins were mixed with the lysis buffer (9.6 M urea, 
1% NP-40,2% carrier Ampholite and 2 mM DTT) and applied imme- 
diately to NEPHGE which was carried out at 400 V (2.4 mm x 18 cm) 
in a Protean II apparatus (Bio-Rad). The gels were excised from the 
tubes, soaked for 15 min in the SDS-PAGE buffer and reloaded onto 
a 12% SDS-polyacrylamide gel (20 x 20 cm). 
2.1. Amino-terminal peptide sequence analysis 
Samples of both MIF isoforms were dialysed extensively against 10 
mM ammonium carbonate. Each sample was directly applied to a 
polybrene precycled glass fiber filter. An Applied Biosystems Model 
477A protein sequencer was used. 
2.8. Circular dichroism (CD) spectroscopy and analysis of CD spectra 
The CD spectra were recorded with a Jobin-Yvon Mark VI dichro- 
graph. The spectra were measured with quartz squared cuvettes (0.2 
cm Hellma) in 20 mM phosphate, pH 7.3, at 20°C. Data were averaged 
over 10 repetitive scans. Protein concentrations were estimated by 
means of molar extinction coefficient at il 278 nm, E = 12,600 
M-‘zrn-‘. The circular dichroism (LIE) was calculated using a mean 
residual weight of 108 and expressed as M-‘.cm-’ units. 
2.9. Computer analyses of protein sequences and protein database 
The secondary structure of MIF was predicted with the SEQPRO 
program using the CD-constrained procedure [13]. The predicted a- 
helical segments were analyzed for potential amphipathic haracter 
using the Fourier transform procedure [14]. Hydrophobicity profiles 
were calculated with SEQPRO using a nine-residue window and the 
Kyte-Doolittle hydrophobicity scale [IS]. Hydrophobicity index (H,) 
was calculated as a ratio of the amino acid residues being in the 
hydrophobic segments with respect o their total. The current edition 
of the MIPSX protein database (rel. 33) containing 61,811 sequences 
was analyzed with SEQPRO. 
3. RESULTS AND DISCUSSION 
The isolation procedure of bovine MIF comprises the 
following three steps. First, there was a general sorting 
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Fig. 2. (A) Comparison of the N-terminal sequences of human [8] and 
bovine MIF. * Indicates the mutation in the amino acid sequence. (B) 
The predicted secondary structure of human MIF. Hydrophobic pep- 
tide segments are designated by tH+; a, a-helix; j?, @tructure; t, 
B-turn; predicted glycosylation sites are indicated by an arrow. The 
hydrophobic peptide segments correlate well with the two predicted 
b-strands (Bl and 82) and the a-helices (a2Lz4). It is likely that the 
main feature of the folded protein is its hydrophobic core (Bl, 82, a3 
and a4) the segments of which are connected by a long hydrophilic 
loop comprising @urn-a-helix-B-turn (13-34) and the B-turns ( 13- 
16), (52-55), and (72-75). 
_ 6.0 
'; 
j 
g 40 
A 
210 220 230 240 250 
Wavlength (nm) 
60 
60 
'; 
B 40 
'i 
d" 20 
00 
-20 
-40 
190 200 210 220 230 240 250 
Wavlength (nm) 
Fig. 3. The far-UV CD spectra of bovine MIF. (A) Isoform with pI 
9.5. (B) Isoform with pI 9.4. 
of proteins on a weak anion exchanger. Second, the 
basic proteins isolated from the first step were fraction- 
ated according to their p1 values on a chromatofocusing 
column (see Fig. 1A). Third, the proteins with PI’S in the 
range 10.5-9.2 were further fractionated on a weak cat- 
ion exchanger to which a salt gradient was applied (see 
Fig. IB). We focused our interest on the two proteins 
that eluted at salt concentrations equal to 0.25 and 0.30 
M NaCl(0.3 mg of each protein was purified from 1 kg 
of dry brain matter). The two proteins are characterized 
by p1 values equal to 9.5 and 9.4, as derived from 2D 
gel electrophoresis experiments. Both the basic p1 and 
the molecular weights of the two proteins are compati- 
ble with those of the 12 kDa recombinant human MIF 
[8]. The amino acid sequences of the first 39 N-terminal 
residues are identical in both proteins, and these N- 
terminal sequences hare nearly 95% identity with that 
of the 12 kDa human recombinant MIF. Only the fol- 
lowing three differences were noted between the three 
sequences. The initiation methionine found in the 12 
kDa human recombinant MIF lacks the two bovine 
proteins which both start by a proline residue. The two 
235 
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other differences are clearly conservative substitutions 
(see Fig. 2A). A search of the current edition of the 
in the augmentation of macrophage-dependent killing 
MIPSX protein database revealed no sequence homol- 
of tumor cells [IO] and the intracellular parasite Leish- 
mania donovani [9] remains obscure. Likewise its in- 
ogy with any of 61,811 proteins sequences except the 12 
kDa human recombinant MIF [8]. On the basis of the 
volvment in the process of chronic inflammation [3,6] 
and graft vs. host diseases [4,5] remains to be elucidated. 
above evidence, we concluded therefore that the two The availability of MIF isolated from various mammal- 
isolated proteins are the MIF isoforms of bovine brain ian sources should allow for a better illumination of the 
cytosol. physiological actions exerted by this lymphokine. 
The far-UV CD spectra of both isoforms of bovine 
MIF exhibit strong CD bands with minima at about 1 
222 nm and 2 208 nm and a maximum at about il 197 
nm (see Fig. 3). The CD-estimated values of a-helix and 
b-structure were 43% (? 3%) and 21% (+ 3%) for the 
MIF isoform with a p1 of 9.5, and 41% (+ 3%) and 20% 
(2 3%) for another MIF isoform with a p1 of 9.4. There 
is a difference in the CD profiles of the MIF isoforms 
(see Fig. 3) but it remains to be established if this differ- 
ence is due to a chemical modification of bovine MIF 
or other factors. The secondary structure of human 
MIF was predicted using its full amino acid sequence 
[8] and the CD-constrained algorithm [ 131 (see Fig. 2B). 
Human MIF has a substantial hydrophobicity index 
(H, = 44.4%) and according to our prediction consists 
of two hydrophobic P-strands ($1 (2-10) and p2 (36- 
46)) two amphipathic a-helices (a3 (58-71) and a4 (788 
91)) and a hydrophilic a-helix (~4) at the C-terminal 
end. There are also two consensus equences for aspar- 
agine-linked glycosylation which are in the solvent-ex- 
posed parts of the protein, namely (72)-NRS, which 
forms a B-turn, and (109)-NNS, which lies on the edge 
of the C-terminal a-helix. 
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